EVFM logo
Evofem Biosciences, Inc.(EVFM)
$0.01—Stale · unknown old

Russell 2000 below the 50-day average

Overview →

EVFM News

About

evofem is a biotechnology company focusing on developing innovative reproductive health products for women in every global market. evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. women need access to effective products that are well suited to their lifestyle and consistent with their core values. products include: amphora™ - a non-hormonal vaginal gel being investigated for contraceptive and microbicidal properties.

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Saundra Pelletier
Leadership (5)
Saundra PelletierInterim Chair, President & Chief Executive Officer
Amy RaskopfChief Business Development Officer
Ellen ThomasChief of Staff
Ivy ZhangChief Financial Officer & Secretary
Kathy Gallo-DoyleSenior Vice President of Commercial Operations
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.